Army chief Gen Waker sets off on trip to Czechia, Slovakia

Dhaka, June 28 -- Army chief Gen Waker-Uz-Zaman has left for the Czech Republic and Slovakia on a five-day official visit. He departed on Sunday, according to a post by the Inter-Services Public Rela... Read More

Over half of licensed hydropower projects in Nepal show weak progress

Kathmandu, June 28 -- The 139.5 MW Lower Manang Marsyangdi Hydropower Project obtained its production license in 2018. Its Power Purchase Agreement (PPA) was signed in 2023, according to the Departmen... Read More

Messi magic seals Argentina's perfect group stage with 3-1 win over Jordan

Texas, June 28 -- Lionel Messi came off the bench to score a trademark free-kick as Argentina completed a flawless Group J campaign with a 3-1 victory over Jordan, sealing top spot and a place in the ... Read More

One killed over mango harvesting dispute in Rajshahi

Rajshahi, June 28 -- A man was killed following a dispute over mango harvesting in Mohanpur upazila of Rajshahi on Saturday evening. The deceased was identified as Abdur Razzak, 45, son of Bhugor Mon... Read More

Dhaka 41st among world's most polluted cities

Dhaka, June 28 -- Dhaka ranked 41st among the world's most polluted cities on Sunday morning, recording an Air Quality Index (AQI) score of 66 at 10:00am. The air quality was classified as "moderate"... Read More

Singapore Clinical Trial: A Phase 1 randomized, double-blind, placebo-controlled, single-ascending-dose study investigating the safety and tolerability of ARD001 in healthy adult subjects and a Phase 2 open-label, multiple-dose study in adult subjects with hemophilia A

Singapore, June 28 -- The Health Sciences Authority received information related to the study titled 'A Phase 1 randomized, double-blind, placebo-controlled, single-ascending-dose study investigating ... Read More

Singapore Clinical Trial: A Multinational, Multicenter Study With an Open-Label Phase 1b and a Randomized, Double-Blind, Placebo-Controlled Phase 3 Followed by an Open-Label Extension to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of Radiprodil in Participants With GRIN-Related Neurodevelopmental Disorder

Singapore, June 28 -- The Health Sciences Authority received information related to the study titled 'A Multinational, Multicenter Study With an Open-Label Phase 1b and a Randomized, Double-Blind, Pla... Read More

Singapore Clinical Trial: A Global, Multicenter, Prospective, Controlled, Open-Label Pivotal Study of Iodofalan (131I) Solution for Injection (TLX101-Tx) Plus Lomustine Versus Lomustine Alone in Patients with Radiographically Confirmed Recurrent Glioblastoma at First Recurrence (IPAX-3)

Singapore, June 28 -- The Health Sciences Authority received information related to the study titled 'A Global, Multicenter, Prospective, Controlled, Open-Label Pivotal Study of Iodofalan (131I) Solut... Read More

Singapore Clinical Trial: RASolute 303: A Phase 3 Global, Multicenter, Open-label, Randomized, 3-Arm Study of Daraxonrasib Monotherapy or Daraxonrasib Plus Gemcitabine and Nab-paclitaxel versus Gemcitabine and Nab-paclitaxel as a First-Line Treatment for Patients with Metastatic Pancreatic Adenocarcinoma

Singapore, June 28 -- The Health Sciences Authority received information related to the study titled 'RASolute 303: A Phase 3 Global, Multicenter, Open-label, Randomized, 3-Arm Study of Daraxonrasib M... Read More

Singapore Clinical Trial: A Multicenter, Multi-Part, Phase 1/2 Study of EIK1005 as Monotherapy and in Combination with Pembrolizumab in Participants with Advanced Solid Tumors, including Participants with Microsatellite Instability High (MSI-H) or Mismatch Repair Deficient (dMMR) Tumors

Singapore, June 28 -- The Health Sciences Authority received information related to the study titled 'A Multicenter, Multi-Part, Phase 1/2 Study of EIK1005 as Monotherapy and in Combination with Pembr... Read More

• «
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• »
• »»